PI3K-AKT signaling is one of the key pathways promoting the metastasis in OS, and inhibition of PI3K-AKT signaling yields enhanced antitumor activity, impaired tumor growth, and reduced migratory and metastatic potential (38, 39). The gene discussed is AKT1; the disease is neoplasm.